Immunoassay Systems

Immunoassay Systems

Global Immunoassay Systems Market to Reach US$29.9 Billion by 2030

The global market for Immunoassay Systems estimated at US$23.2 Billion in the year 2023, is expected to reach US$29.9 Billion by 2030, growing at a CAGR of 3.7% over the analysis period 2023-2030. Immunoassay Reagents & Kits, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$19.4 Billion by the end of the analysis period. Growth in the Immunoassay Analyzers / Instruments segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$6.3 Billion While China is Forecast to Grow at 6.4% CAGR

The Immunoassay Systems market in the U.S. is estimated at US$6.3 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.2 Billion by the year 2030 trailing a CAGR of 6.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.8% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Immunoassay Systems Market - Key Trends and Drivers Summarized

Immunoassay systems are indispensable tools in clinical diagnostics and biomedical research, employing biochemical tests to measure specific macromolecules or small molecules in complex mixtures. They leverage antibody-based reactions for sensitive and specific detection and quantification of antigens or antibodies in various body fluids, playing a vital role in qualitative and quantitative analysis of biological samples. The market for these systems is poised for continuous growth, driven by technological advancements, the increasing burden of diseases like diabetes and cancer, and the expanding global healthcare infrastructure, especially in managing age-related conditions among the elderly.

Advancements in technology have led to the development of sophisticated immunoassay systems with enhanced sensitivity, faster results, and greater throughput. Technologies such as chemiluminescence immunoassay (CLIA) and enzyme-linked immunosorbent assay (ELISA) are in demand for their improved accuracy and reliability. Moreover, automation and integration with laboratory information systems (LIS) are trends shaping the future of immunoassay systems, reducing human error and enhancing diagnostic workflows. Portable systems for point-of-care testing are also gaining traction, particularly in managing chronic diseases and emergency medicine, where rapid decision-making is crucial.

Additionally, customization, flexibility, and a focus on precision medicine are driving the demand for immunoassay systems tailored to specific laboratory needs. Multiplexed immunoassays, allowing simultaneous measurement of multiple analytes, are gaining popularity for their comprehensive analysis of biological samples. . Immunoassay systems are vital for identifying biomarkers and specific disease states, thus supporting personalized treatment plans. Laboratories are increasingly looking for immunoassay systems that can be customized to their specific needs. Systems that offer flexibility in terms of scalable throughput, open reagent systems, and a broad menu of tests are particularly appealing. Moreover, sustainability and eco-friendliness are becoming key considerations in system design, with manufacturers focusing on reducing energy consumption and waste production, aligning with global sustainability goals.

Select Competitors (Total 29 Featured) -

• Abbott Laboratories
• Beckman Coulter Inc.
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• DiaSorin S.p.A
• Ortho-Clinical Diagnostics Inc.
• Quidel Corporation
• Roche Diagnostics
• Siemens Healthineers
• Sysmex Corporation
• Tosoh Bioscience Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.